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Neuronal Fe65 is a central adapter for the intracellular protein network of Alzheimer’s disease
related amyloid precursor protein (APP). It contains a unique tandem array of phosphotyrosine-
binding (PTB) domains that recognize NPXY internalization motifs present in the intracellular
domains of APP (AICD) and the low-density lipoprotein receptor-related protein LRP1 (LICD). The
ternary APP/Fe65/LRP1 complex is an important mediator of APP processing and affects b-amyloid
peptide production. Here we dissect by biochemical and biophysical methods the direct interactions
within the ternary complex and reveal a phosphorylation-dependent insulin receptor substrate
(IRS-) like interaction of the distal NPVY4507 motif of LICD with Fe65-PTB1.
Structured summary of protein interactions:
APP-AICD and FE65 bind by nuclear magnetic resonance (View interaction)
Src phosphorylates LRP1-LICD by protein kinase assay (View interaction)
LRP1-LICD physically interacts with FE65 and APP-AICD by pull down (View interaction)
FE65-PTB1 and LRP1-LICD bind by nuclear magnetic resonance (View interaction)
LRP1-LICD binds to FE65-PTB1 by pull down (View interaction)
APP-AICD binds to FE65-PTB2 by pull down (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Alzheimer’s disease (AD) is the most common form of dementia
characterized by the formation of senile plaques and neuroﬁbril-
lary tangles [1]. The plaques contain aggregations of the b-amyloid
peptide (Ab), which is generated by proteolysis of the amyloid pre-
cursor protein (APP). Stimulation of proteolysis depends on the cel-
lular localization of APP, which is regulated by a complex protein
network. The low-density lipoprotein receptor-related protein
(LRP1), a member of the LDL receptor superfamily [2], is an endo-
cytic receptor for APP and critically involved in APP processing and
signaling [3–7]. APP and LRP1 are linked by the neuronal adapter
protein Fe65 [8–10]. Fe65 is a cytosolic protein containing a WW
domain and a unique tandem array of phosphotyrosine-binding
(PTB) domains (Fe65-PTB1 and -PTB2).
PTB domains are Pleckstrin-homology like modules specialized
in membrane-proximal recognition of canonical NPXpY signals
(X: any residue, pY: phosphotyrosine) for rapid internalization bychemical Societies. Published by E
rsity Biochemistry Center, Im
y. Fax: +49 6221 544790.
.de (K. Wild).clathrin-mediated endocytosis [11]. The NPXpY ﬁngerprint is
found in the cytoplasmic tails of a subset of type I transmembrane
proteins and might also be recognized in a non-phosphorylated
NPXY state [12]. The PTB domain family has therefore been divided
in a Dab-like pY-independent sub-family and the Shc- and IRS-like
pY-dependent sub-families. Dab-like Fe65-PTB2 has been shown
previously to recognize the non-phosphorylated NPTY687 sequence
(neuronal APP695 numbering) of the APP intracellular domain
(AICD, residues 646–695) [13], and the structure of the AICD/
Fe65-PTB2 complex [14] revealed an extended and unique inter-
face regulated by phosphorylation of a proximal threonine residue
T668 [14,15]. Fe65-PTB1 has been implicated in binding the LRP1
intracellular domain (LICD, residues 4445–4544) [9,10], which
extraordinarily contains two NPXY motifs (proximal: NPTY4473,
distal: NPVY4507) with different phosphorylation sensitivity by
Src-kinases and executing different functions [16,17]. In contrast
to Fe65-PTB2, the structure of Fe65-PTB1 in complex with inor-
ganic phosphate suggested that substrates of Fe65-PTB1 might
bind in a pY-dependent manner [18]. Using for the ﬁrst time puri-
ﬁed protein samples, we show by biochemical and biophysical
methods that Fe65 constitutes the structural linker between AICD
and LICD, dissect the binding regions, and prove that the LICD/
Fe65-PTB1 interaction is phosphorylation dependent.lsevier B.V. All rights reserved.
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2.1. Cloning, protein expression, and puriﬁcation
Fe65-PTB1 (G366-A509), Fe65-PTB2 (A534-Q666), and Fe65-PTB1/2
(G366-Q666) constructs contain a C-terminal hexa-histidine tag and
were puriﬁed as described [19,20]. The Fe65-PTB1 R451R470-AA
double mutant was generated by in vitro mutagenesis using the
QuikChange site directed mutagenesis kit (Stratagene). Mutant
Fe65-PTB1 was puriﬁed as the wild-type protein.
AICD and LICD were produced as C-terminal glutathione-
S-transferase (GST) and thioredoxin (Trx) fusion proteins. For
GST-fusions, LICD constructs (LICD: K4445-A4544, LICD-N: K4445-
P4496, LICD-C: D4491-A4544, LICD-C37: A4508-A4544) and AICD-C32
(D664-N695) were cloned into a modiﬁed pGAT2 vector (without
histidine-tag). The proteins contain an N-terminal GST tag fol-
lowed by a thrombin cleavage site and a C-terminal hexa-histidine
tag, which was introduced via reverse primers. AICD (V646-N695)
was cloned into the pGEX4T-2 vector leading to an N-terminal
GST tag followed by a thrombin cleavage site but lacking the C-ter-
minal histidine tag. For Trx-fusions the respective sequences for
LICD (LICD: N4461-A4544, LICD-N: N4461-P4496, LICD-C: D4497-A4544)
and AICD-C32 (D664-N695) were cloned into pETtrx_1b (G. Stier,
Heidelberg) with an N-terminal Trx tag followed by a hexa-
histidine tag and a TEV cleavage site. Proteins were expressed in
BL21(DE3)RIL cells at 37 C and essentially puriﬁed as the Fe65
constructs (SEC columns: Superdex S200 for GST-fusions and S30
for Trx-fusions, GE Healthcare). In order to remove the Trx tag after
TEV protease cleavage, the dialyzed Ni-column eluate was appliedFig. 1. Constructs, puriﬁed proteins, and protein phosphorylation. (A) Overview of APP-,
puriﬁed GST-fusion proteins. (C) Quantiﬁcation of the phosphorylation reaction by autora
the applied standard conditions. Phosphorylation of wildtype LICD-C (including two ty
NPVY4507 tyrosine. (D) Phosphorylation of LICD constructs by c-Src kinase. While the succ
bands without phosphorylation), phosphorylation of LICD-C was validated by MS analys(without imidazole) to the same column before the SEC. If used as
prey in GST pull-down experiments the Trx-fusions were tested
with and without Trx tag. For NMR purposes Trx-fusions were
TEV-cleaved.
The sequence for c-Src tyrosine kinase domain (residues 251–
533) was cloned into a modiﬁed pET-28a vector (Novagen) in order
to yield a TEV protease cleavable N-terminal hexa-histidine tag.
The protein was expressed, puriﬁed as described [21] and stored
at 80 C until further used. To assure activity of the puriﬁed pro-
tein a kinase assay was performed [16].2.2. Protein phosphorylation
For phosphorylation of the LICD NPXY motifs puriﬁed GST-
fusions and Trx-fusions (either with or without Trx tag) were incu-
bated with puriﬁed c-Src kinase domain in molar ratios of 1/2000
at 30 C for 2 h and of 1/1000 at 23 C for 1.5 h, respectively. Reac-
tion took place in 100 mM Tris (pH 7.5), 150 mM NaCl, 10 mM
MnCl2, 10 mM MgCl2, 10 mM ATP, and 1 mM DTT at a protein con-
centration of 4.5 mg/mL. After incubation proteins were again ap-
plied to SEC columns equilibrated in 100 mM Tris (pH 7.5),
150 mM NaCl and 0.02% (v/v) mono-thioglycerol to remove the ki-
nase. Successful phosphorylation was checked by tryptic digestion
followed by mass spectrometry (MS) and Western Blot analysis
with a monoclonal anti-pY antibody (P-Tyr-100, Cell Signaling
Technology). Speciﬁc phosphorylation of the NPXY motifs was
exemplary veriﬁed for Trx-fusions by tryptic digest followed by
Orbitrap mass spectrometry (MS).Fe65-, and LRP1-constructs used in this study. (B) Coomassie-stained SDS–PAGE of
diography. Complete phosphorylation of LICD-C is reached in less than 30 min under
rosines) is identical to the LICD-C Y4511F mutant, which only contains the distal
essive modiﬁcation of LICD-N can be followed by SDS–PAGE (LICD-Nmigrates as two
is and autoradiography.
Fig. 2. The APP/Fe65 interaction. (A) GST pull-downs for the AICD/Fe65-PTB2 interaction. The Fe65-PTB2 dimer is an SDS–PAGE artefact [19,20]. (B) The AICD/Fe65-PTB1/2
interaction. (C) Fe65-PTB1 is not binding to the AICD. (D) 1H,15N-HSQC spectra. The absence of resonance shifts in the superposition of the spectra for Fe65-PTB1/2 (blue,
300 lM) with individual Fe65-PTB1 (red, 300 lM) and Fe65-PTB2 (green, 100 lM) indicates that the domains do not interact.
W. Klug et al. / FEBS Letters 585 (2011) 3229–3235 32312.3. Autoradiography
To quantify phosphorylation efﬁciency of the Trx-fusion pro-
teins, autoradiography was carried out in the same conditions as
described in protein phosphorylation. The reaction was initiated
by adding 10 mM ATP which additionally contained 0.75 lCi of
[gamma-32P] ATP (SRP-301; 3000 Ci/mmol) (Hartmann Analytic
GmbH, Braunschweig, Germany). At given time points aliquots
were taken and the reaction was stopped by adding 2  SDS load-
ing dye (152 lM Tris (pH 6.8), 4% (w/v) SDS, 10% (v/v) b-mercap-
toethanol, 10% (v/v) glycerol, and 0.02% (w/v) bromphenol blue)
and samples were resolved by SDS–PAGE. The gels were dried
and incorporation of 32P was followed using a PhosphoImager Sys-
tem (FujiFilm, Japan). Experiments were done in triplicates.
2.4. GST pull-down experiments
To immobilize either GST alone or the different constructs of
LICD/AICD fused to GST, glutathione-sepharose beads (10 lL) were
incubated with 20 lM of bait protein in a buffer consisting of
100 mM Tris (pH 7.5), 150 mM NaCl, and 0.02% (v/v) mono-
thioglycerol at 4 C. Washing was performed three times in the
same buffer and incubation with the prey (110–230 lM) was
carried out for 2 h at 4 C in the presence of BSA (1–2 mg/mL).
Subsequently the beads were washed again and bound proteinwas eluted in the same buffer supplemented with 10 mM glutathi-
one. Alternatively, for ternary complex formation, beads were
additionally incubated with LICD or AICD (up to 230 lM) puriﬁed
from Trx-fusion constructs (either with or without Trx tag) prior
to ﬁnal washing and elution. Proteins were detected by SDS–PAGE
and Coomassie Brilliant Blue R (Sigma) staining.
2.5. Nuclear magnetic resonance (NMR)
1H,15N heteronuclear single quantum experiments (HSQC) spec-
tra were recorded on 15N labeled protein at a temperature of 300 K.
Protein concentrations ranged from 0.1 to 0.6 mM in buffers con-
taining either 10 mM Hepes (pH 6.5) and 150 mM NaCl or
20 mM Na2HPO4 pH 6.5 and 100 mM NaCl on Bruker DRX 500 or
AvanceII 800 MHz spectrometer. Spectra where analyzed using
the programs Topspin (Bruker) and NMRPipe [22].
3. Results and discussion
3.1. Speciﬁc NPXY phosphorylation of the LICD by c-Src kinase
Phosphorylation of NPXY motifs is a crucial determinant for
binding speciﬁcity to many PTB domains and regulates the biolog-
ical signal associated with the interaction [12]. In order to in vitro
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fore performed binding studies with non-phosphorylated and
phosphorylated proteins, the latter being modiﬁed by overexpres-
sed c-Src kinase domain. Expression and puriﬁcation of all APP-,
Fe65-, and LRP1-constructs (Fig. 1A) yielded high amounts of pure
protein (Fig. 1B). To optimize the phosphorylation process for the
NPXY motifs of LICD, various conditions were tested with puriﬁed
LICD Trx-fusions after TEV-cleavage and then adapted to the GST-
fusions. Successful and speciﬁc phosphorylation at the respective
tyrosines in the NPXY motifs by c-Src kinase was conﬁrmed by
MS analysis and Western Blot using an anti-pY antibody, and com-
pletion of phosphorylation was assured by a triplication of the nec-
essary reaction time as veriﬁed in a radioactive ATP hydrolysis
assay (Fig. 1C). Interestingly, phosphorylation coincides with pro-
nounced shifts to higher apparent molecular weight on SDS–PAGE
for LICD-N, but with only a marginal shift for LICD-C (Fig. 1D).
3.2. The APP/Fe65 interaction
In order to dissect direct interactions within the APP/Fe65/LRP1
complex, we systematically analyzed the interactions by GST
pull-down assays. First we challenged our assay by the validatedFig. 3. The LRP1/Fe65 interaction. (A) GST pull-down assays show that the LICD/Fe65-PT
the LICD-C construct. (B) Superposed 1H,15N-HSQC spectra conﬁrming the phosph
phosphorylated (1 mM): green). More resonances shift and to a greater extent for pLIC
(200 lM): black, +LICD phosphorylated (500 lM): red, +LICD-C phosphorylated (500 lMinteraction of the AICD with the Fe65-PTB2 domain (Fig. 2A). Using
either the full-length AICD or the truncated AICD-C32 as bait, we
ﬁnd a strong pull-down which goes in-line with a low dissociation
constant of 0.2 lm for both AICD constructs as determined by our
previous biophysical study [14]. We then analyzed if the tandem
Fe65-PTB1/2 construct still allows for efﬁcient binding to the AICD,
which indeed does not interfere with complex formation (Fig. 2B).
Finally we tested, if also Fe65-PTB1 is able to bind to the AICD. We
could not detect any binding (Fig. 2C), conﬁrming previous data
showing that Fe65 is recruited to APP by its C-terminal PTB domain
Fe65-PTB2.
In order to gain further insights into the spatial organization of
the APP/Fe65 complex, we performed heteronuclear single quan-
tum coherence 1H,15N-HSQC NMR measurements. In continuation
of our previous NMR experiments for the AICD/Fe65-PTB2 complex
[14], we ﬁrst wanted to elucidate if Fe65-PTB1 and Fe65-PTB2 are
merged into a single folded unit or if the two domains behave like
pearls on a string without any tertiary interactions. Adding excess
of unlabeled Fe65-PTB2 in trans does not change the spectrum of
Fe65-PTB1 (data not shown) and there are no signiﬁcant chemical
shift changes observed comparing Fe65-PTB1/2 to the individual
Fe65-PTB1 and -PTB2 domain spectra (Fig. 2D). This suggests thatB1 interaction is phosphorylation dependent. Fe65-PTB1 interacts exclusively with
orylation dependence (Fe65-PTB1 (350 lM): black, +LICD (1 mM): red, +LICD
D (green). (C) LICD-C contains all binding determinants to Fe65-PTB1 (Fe65-PTB1
): green). Red and green spectra superpose completely.
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can interact as independent modules.
3.3. The LRP1/Fe65 interaction
Fe65-PTB1 has been previously shown to bind to the LICD both
in vitro and in vivo [8–10]. Based on our crystal structure of Fe65-
PTB1 in complex with inorganic phosphate, we postulated this
interaction to be phosphorylation dependent [18]. Taking full-
length LICD as bait, we clearly detect a phosphorylation dependent
interaction (Fig. 3A) and therefore conﬁrm our previous hypothe-
sis. However, the pull-down efﬁciency is much lower than for the
AICD/Fe65-PTB2 interaction, indicating a weaker association of
LICD with Fe65-PTB1. We then split the LICD in two halves
(LICD-N, LICD-C) in order to distinguish which one of the two NPXY
motifs is responsible for Fe65 binding, which is controversially re-
ported in the literature [8–10]. The respective pull-downs proveA
C
B
Fig. 4. The LICD-NPVpY4507/Fe65-PTB1 interaction. (A) LICD-C37 (without the distal NPVY
binding pocket impairs binding to the LICD. (C) Model for the LICD-NPVpY4507/Fe65-PTB1
(N-term) to red (C-term). LICD-NPVpY4507 (black) is modeled according the NPXpY structhat only the distal NPVY4507 motif is able to bind to Fe65-PTB1
and again only when the tyrosine is phosphorylated (Fig. 3A).
LICD-N including the proximal NPTY4473 motif does not alter the
global afﬁnity for Fe65-PTB1 and is therefore unlikely to contact
Fe65-PTB1 or to form extensive tertiary interactions with LICD-C.
Moreover, neither of the LICD constructs could be pulled with
Fe65-PTB2 nor could LICD-N be pulled with Fe65-PTB1/2 (data
not shown), conﬁrming that LICD-C/Fe65-PTB1 includes all major
binding determinants.
We next set out to conﬁrm the pY-dependence of the LRP1/Fe65
interaction by 1H,15N-HSQC measurements. In the NMR experi-
ments, we observe small chemical shift changes for 15N labeled
Fe65-PTB1 upon adding excess of unlabeled LICD (Fig. 3B). Upon
the addition of phosphorylated LICD, more resonances shift and
the overall spectral changes are larger, indicating an extended
interaction surface and tighter binding. When LICD-N is used in-
stead of full-length LICD, or wild-type Fe65-PTB1 is exchanged4507) fails to bind Fe65-PTB1. (B) The Fe65-PTB1 double arginine mutation in the pY-
complex. IRS-like Fe65-PTB1 (PDB code 3D8F) is shown in a colour ramp from blue
ture of the IL-4 phospho-peptide bound to IRS1-PTB (1IRS, superposed onto 3D8F).
AB
Fig. 5. The ternary APP/Fe65/LRP1 complex. (A) GST pull-down assays for the AICD/LICD and the ternary AICD/Fe65-PTB(1/2)/LICD complex. (B). Schematic of the APP/Fe65/
LRP1 complex. AICD binds unphosphorylated to Fe65-PTB2 as described [14] and LICD binds phosphorylated with its distal NPVpY4507 motif to Fe65-PTB1.
3234 W. Klug et al. / FEBS Letters 585 (2011) 3229–3235for the double-arginine mutant, no interaction can be detected
independent of any phosphorylation (data not shown). In contrast,NMR studies using LICD-C explain all shifts obtained with full-
length LICD (Fig. 3C).
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classical binding pattern of the NPXY endocytosis signal in a pocket
within the PTB domain as characterized for several other systems
[12]. We therefore used an LICD fragment starting C-terminal to
the distal NPVY4507 motif (LICD-C37) for GST pull-down assays.
This construct, which has been shown to promote amyloidogenic
processing of APP independent of Fe65 [23], completely fails to re-
cruit Fe65-PTB1 (Fig. 4A). To further dissect the interaction, we
mutated the two conserved arginines in the binding pocket (R451
and R470 to alanines), which according to respective residues in
the IRS-PTB family are responsible for phosphotyrosine recogni-
tion, and which were found to coordinate inorganic phosphate in
the Fe65-PTB1/Pi structure [18]. In pull-down experiments with
phosphorylated LICD-C, the mutants are shown to be strongly im-
paired in complex formation (Fig. 4B), ﬁnally conﬁrming the IRS-
like mode of the LICD-C/Fe65-PTB1 interaction (Fig. 4C).
3.4. The ternary APP/Fe65/LRP1 complex
Having validated the binary interactions, we aimed at the dis-
section of the ternary APP/Fe65/LRP1 complex (Fig. 5A). In order
to check if the AICD is able to directly bind to the LICD indepen-
dently of Fe65, we performed pull-downs using either AICD or LICD
as bait. This AICD/LICD complex could not be observed, highlight-
ing the bridging function of Fe65 in the ternary complex. In a
minimal ternary complex, Fe65-PTB1/2 should bind to both the
AICD-C32 and the LICD-C fragments, with the latter being phos-
phorylated. Indeed, this complex can be pulled, but with lower efﬁ-
ciency as for the binary LICD/Fe65-PTB1 complex. We then
extended the ternary complex to full-length LICD. Interestingly,
this complex forms as the binary complex (Fig. 5A), however, the
inﬂuence of LICD phosphorylation is less pronounced, revealing a
still more intricate interaction pattern.
4. Conclusions
Taken together, we biochemically and biophysically character-
ize and validate the interactions of Fe65-PTB1/2 with the AICD
and LICD. The interaction comprises two rather independent bind-
ing events, with Fe65-PTB2 binding to the non-phosphorylated
AICD [14], and Fe65-PTB1 recognizing the LICD region centered
on the phosphorylated distal NPVY4507 motif (Fig. 5B). However,
the complete interaction remains to be structurally validated and
it is unclear how this Alzheimer relevant protein network is regu-
lated in context of the membrane, and the various other NPXY mo-
tifs and PTB domains present in neurons.
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